Cargando…
Therapeutic Vaccination With Recombinant Adenovirus Reduces Splenic Parasite Burden in Experimental Visceral Leishmaniasis
Therapeutic vaccines, when used alone or in combination therapy with antileishmanial drugs, may have an important place in the control of a variety of forms of human leishmaniasis. Here, we describe the development of an adenovirus-based vaccine (Ad5-KH) comprising a synthetic haspb gene linked to a...
Autores principales: | Maroof, Asher, Brown, Najmeeyah, Smith, Barbara, Hodgkinson, Michael R., Maxwell, Alice, Losch, Florian O., Fritz, Ulrike, Walden, Peter, Lacey, Charles N. J., Smith, Deborah F., Aebischer, Toni, Kaye, Paul M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274377/ https://www.ncbi.nlm.nih.gov/pubmed/22301630 http://dx.doi.org/10.1093/infdis/jir842 |
Ejemplares similares
-
Compartment-Specific Remodeling of Splenic Micro-Architecture during Experimental Visceral Leishmaniasis
por: Yurdakul, Pinar, et al.
Publicado: (2011) -
Cutaneous parasitism in patients with American visceral leishmaniasis
in an endemic area
por: Moura, Carla Riama Lopes de Pádua, et al.
Publicado: (2020) -
Single Dose Novel Salmonella Vaccine Enhances Resistance against Visceralizing L. major and L. donovani Infection in Susceptible BALB/c Mice
por: Schroeder, Juliane, et al.
Publicado: (2011) -
Skin parasite landscape determines host infectiousness in visceral leishmaniasis
por: Doehl, Johannes S. P., et al.
Publicado: (2017) -
IL-10-Producing Th1 Cells and Disease Progression Are Regulated by Distinct CD11c(+) Cell Populations during Visceral Leishmaniasis
por: Owens, Benjamin M. J., et al.
Publicado: (2012)